Spectral Med Inc Market Cap ($215.43 Million)
Market Cap & Net Worth: Spectral Med Inc (EDT)
Spectral Med Inc market cap. Spectral Med Inc (TO:EDT) has a market capitalization of $215.43 Million (CA$297.81 Million) as of November 1, 2026. Listed on the TO stock exchange, this Canada-based company holds position #16064 globally and #480 in its home market, demonstrating a -4.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Spectral Med Inc's stock price CA$1.03 by its total outstanding shares 289138820 (289.14 Million). Also see EDT operating cash flow for how efficiently the company converts equity into cash flow.
Spectral Med Inc Market Cap History (2015–2026)
Spectral Med Inc market cap history from 2015 to 2026. Data shows growth from $169.42 Million to $215.43 Million (2.32% CAGR). Check EDT stock price and chart for real-time trading data and today's change.
Spectral Med Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Spectral Med Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Spectral Med Inc equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
45.75x
Spectral Med Inc's market cap is 45.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $169.42 Million | $3.09 Million | -$9.52 Million | 54.85x | N/A |
| 2016 | $57.52 Million | $3.54 Million | -$10.15 Million | 16.23x | N/A |
| 2017 | $79.48 Million | $3.67 Million | -$4.08 Million | 21.66x | N/A |
| 2018 | $59.61 Million | $3.84 Million | -$2.49 Million | 15.52x | N/A |
| 2019 | $150.59 Million | $2.87 Million | -$4.86 Million | 52.51x | N/A |
| 2020 | $84.71 Million | $2.10 Million | -$9.10 Million | 40.32x | N/A |
| 2021 | $46.01 Million | $2.00 Million | -$8.79 Million | 23.05x | N/A |
| 2022 | $77.39 Million | $1.67 Million | -$11.28 Million | 46.42x | N/A |
| 2023 | $88.89 Million | $1.60 Million | -$15.66 Million | 55.63x | N/A |
| 2024 | $104.58 Million | $2.29 Million | -$15.40 Million | 45.75x | N/A |
Competitor Companies of EDT by Market Capitalization
Companies near Spectral Med Inc in the global market cap rankings as of November 1, 2026. Also see Spectral Med Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Spectral Med Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Spectral Med Inc (2015–2026)
Market capitalization of Spectral Med Inc from 2015 to today. Between 2015 and today, Spectral Med Inc's market cap moved from $169.42 Million to $ 215.43 Million, with a yearly change of 2.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$215.43 Million | -28.47% |
| 2025 | CA$301.19 Million | +188.00% |
| 2024 | CA$104.58 Million | +17.65% |
| 2023 | CA$88.89 Million | +14.86% |
| 2022 | CA$77.39 Million | +68.18% |
| 2021 | CA$46.01 Million | -45.68% |
| 2020 | CA$84.71 Million | -43.75% |
| 2019 | CA$150.59 Million | +152.63% |
| 2018 | CA$59.61 Million | -25.00% |
| 2017 | CA$79.48 Million | +38.18% |
| 2016 | CA$57.52 Million | -66.05% |
| 2015 | CA$169.42 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Spectral Med Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $215.43 Million USD |
| MoneyControl | $215.43 Million USD |
| MarketWatch | $215.43 Million USD |
| marketcap.company | $215.43 Million USD |
| Reuters | $215.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more